Varian Medical Systems, Inc.

Celonova Biosciences, Inc.

Boston Scientific Corporation

Celonova Bioscience, Inc.

Thomas A Gordy

Ulf Fritz

Olaf Fritz

Ronald Wojcik

Alexander Küller

Jacques Blümmel

Roman Denk

Neng S Ung

Jaques Blummel

Oscar Jimenez

Medical devices include a rigid dome, a viewing window, a vacuum port, a vacuum pressure regulator, an aperture, and a septum. The rigid dome is hemispherical and includes a first dome stage, a second dome stage distal on the first dome stage, and a transition between the first dome stage and the second dome stage. The viewing window is acoustically and\or optically transparent to allow for inspection of the surgical site. The vacuum port allows for a reduction of a pressure on the interior of the rigid dome. The vacuum pressure regulator regulates the pressure on the interior of the rigid dome. The aperture provides access to the interior of the rigid dome and the surgical site. The septum engages with the second dome stage to allow for insertion of a surgical instrument with resistance to loss of the pressure on the interior of the rigid dome.

Medical devices for use in the creation of a temporary pneumoperitoneum

Polymeric particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene and/or a derivative thereof which may be present throughout the particles or within an outer coating of the particles. The particles may also include a core having a hydrogel formed from an acrylic-based polymer. Such particles may be provided to a user in specific selected sizes to allow for selective embolization of certain sized blood vessels or localized treatment with an active component agent in specific clinical uses. Particles of the present invention may further be provided as color-coded microspheres or nanospheres to allow ready identification of the sized particles in use. Such color-coded microspheres or nanospheres may further be provided in like color-coded delivery or containment devices to enhance user identification and provide visual confirmation of the use of a specifically desired size of microspheres or nanospheres.

Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same

Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a hydrogel formed from an acrylic-based polymer. Such particles may be provided to a user in specific selected sizes to allow for selective embolization of certain sized blood vessels or localized treatment with an active component agent in specific clinical uses. Microspheres of the present invention may further be provided with physical and/or chemical enhancements within the particles' cores to enhance visualization of the embolized tissue using a variety of medical imaging modalities, including conventional radiography, fluoroscopy, tomography, computerized tomography, ultrasound, scintillation, magnetic resonance, or other imaging technologies.

Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same

Polymeric particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles may also include a core having a hydrogel formed from an acrylic-based polymer. Such particles may be provided to a user in specific selected sizes to allow for selective embolization of certain sized blood vessels or localized treatment with an active component agent in specific clinical uses. Particles of the present invention may further be provided as color-coded microspheres or nanospheres to allow ready identification of the sized particles in use. Such color-coded microspheres or nanospheres may further be provided in like color-coded delivery or containment devices to enhance user identification and provide visual confirmation of the use of a specifically desired size of microspheres or nanospheres.

This disclosure encompasses a bioprosthetic heart valve having a polyphosphazene polymer such as poly[bis(trifluoroethoxy)phosphazene], which exhibits improved antithrombogenic, biocompatibility, and hemocompatibility properties. A method of manufacturing a bioprosthetic heart valve having a polyphosphazene polymer is also described.

Growing community of inventors

Newnan, GA, United States of America

Thomas A Gordy